Jamie Elizabeth Rosen.

Kaiser Family Basis. Kaiser Health News, an unbiased news service editorially, is a scheduled plan of the Kaiser Family Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.. Aeras, IDRI partner to develop novel TB vaccine In a guest post on the Global Health Technologies Coalition’s ‘Breakthroughs’ blog, Jamie Elizabeth Rosen, mass media and communications manager at Aeras, interviews Steven Reed, founder, president, and chief scientific officer of the Infectious Disease Research Institute , ‘a 120-person non-profit biotech focused on applying innovative science to the study and development of items to prevent, detect, and deal with infectious diseases of poverty.’ Aeras, ‘a non-profit biotech centered on developing vaccines against TB,’ has partnered with IDRI to build up a novel tuberculosis vaccine applicant, Rosen notes and summarizes Reed’s responses to queries regarding TB vaccine advancement .This article was reprinted from kaiserhealthnews.org with permission from the Henry J.There are now 10 new prostate cancers therapies in Phase III clinical trials in comparison to just four in 1997. more dramatically Even, 90 new therapies are in Stage II clinical trials presently, weighed against only 31 in 1997. Information concerning prostate cancers therapies in clinical advancement is now offered by the PCF’s Prostate Cancers Therapeutics Resource Center ( part of the Prostate Malignancy Foundation’s newly redesigned Internet site, accessible at Related StoriesSausages With Antioxidants From Berries To Prevent CancerMD Anderson study reveals why chemotherapy medications not effective for many pancreatic malignancy patientsNew RNA check of blood platelets can be used to identify area of cancerProstate Cancer Foundation CEO Leslie D.